Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,399
Closed -$1.42M 55
2022
Q2
$1.42M Hold
5,399
0.68% 34
2022
Q1
$1.29M Hold
5,399
0.51% 35
2021
Q4
$1.24M Hold
5,399
0.48% 36
2021
Q3
$1.08M Sell
5,399
-5,566
-51% -$1.21M 0.44% 37
2021
Q2
$2.6M Sell
10,965
-145
-1% -$36.2K 0.97% 30
2021
Q1
$2.69M Hold
11,110
1.01% 29
2020
Q4
$2.31M Hold
11,110
0.94% 30
2020
Q3
$1.88M Hold
11,110
0.84% 31
2020
Q2
$2.08M Hold
11,110
0.99% 27
2020
Q1
$1.97M Hold
11,110
1.13% 26
2019
Q4
$2.27M Hold
11,110
1.12% 25
2019
Q3
$1.69M Hold
11,110
0.87% 31
2019
Q2
$1.75M Hold
11,110
0.9% 30
2019
Q1
$1.79M Sell
11,110
-1
-0% -$183 0.94% 29
2018
Q4
$2.11M Buy
+11,111
New +$2.32M 1.28% 25

Other funds holding CI

Thomas Story & Son's CI Position: Q3 2022 in Review

Thomas Story & Son sold out of Cigna (CI) in Q3 2022, closing a stake of 5,399 shares — an estimated $1.42M sold.

Thomas Story & Son first reported a position in CI in Q4 2018 and held it in 15 quarters. The position peaked at $2.69M in Q1 2021. 1,482 funds tracked by Wall St. Rank hold CI as of Q3 2022.

  • Thomas Story & Son reported no remaining Cigna position as of Q3 2022 after selling out during the quarter.
  • Thomas Story & Son sold 5,399 Cigna shares in Q3 2022, an estimated $1.42M.
  • Thomas Story & Son first reported a position in Cigna in Q4 2018 and held it in 15 quarters.
  • Thomas Story & Son's Cigna position peaked at $2.69M in Q1 2021.
  • 1,482 funds tracked by Wall St. Rank held Cigna as of Q3 2022.

Based on Thomas Story & Son's 13F filing for Q3 2022, filed 1 Nov 2022.